Helixate FS (CSL Behring LLC)
Welcome to the PulseAid listing for the Helixate FS drug offered from CSL Behring LLC. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | CSL Behring LLC |
NON-PROPRIETARY NAME: | Antihemophilic Factor, Recombinant |
SUBSTANCE NAME: | |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2000-08-18 |
END MARKETING DATE: | 0000-00-00 |
Helixate FS PLASMA DERIVATIVE Details:
Item Description | Helixate FS from CSL Behring LLC |
LABELER NAME: | CSL Behring LLC |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2000-08-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0053-8131_bc0801dd-a97c-4dc3-8484-4c7344923c27 |
PRODUCT NDC: | 0053-8131 |
APPLICATION NUMBER: | BLA103332 |